Cargando…

Effects of Etanercept on TNF-α Inhibition in Rats with Adenine-Induced Chronic Kidney Disease

INTRODUCTION: Chronic kidney disease (CKD) constitutes a chronic inflammatory state associated with an increase in inflammatory mediators and profibrotic molecules such as tumor necrosis factor-α (TNF-α). Etanercept (ETA) is a TNF inhibitor widely used in treatment of autoimmune inflammatory disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mendieta-Condado, Edgar, Villaseñor-Tapia, Elda Cristina, Gálvez-Gastelum, Francisco Javier, Yáñez-Sánchez, Irinea, Pizano-Martínez, Oscar, Canales-Aguirre, Alejandro, Márquez-Aguirre, Ana Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135514/ https://www.ncbi.nlm.nih.gov/pubmed/35647193 http://dx.doi.org/10.1155/2022/4970753

Ejemplares similares

Recombinant Erythropoietin Provides Protection against Renal Fibrosis in Adenine-Induced Chronic Kidney Disease
por: Vázquez-Méndez, Estefanía, et al.
Publicado: (2020)

Anti-Drug Antibodies in the Biological Therapy of Autoimmune Rheumatic Diseases
por: Pizano-Martinez, Oscar, et al.
Publicado: (2023)

Putrescine treatment reverses α-tocopherol-induced desynchronization of polyamine and retinoid metabolism during rat liver regeneration
por: Sánchez-Sevilla, Lourdes, et al.
Publicado: (2016)

Influence of TNFα–308 and T676G TNF-RII polymorphism on response to etanercept and posibility to discontinue tretment
por: Vojinovic, J, et al.
Publicado: (2011)

Activity of the neuroendocrine axes in patients with polymyalgia rheumatica before and after TNF-α blocking etanercept treatment
por: Kreiner, Frederik Flindt, et al.
Publicado: (2012)

TNF-α Promoter Polymorphisms Predict the Response to Etanercept More Powerfully than that to Infliximab/Adalimumab in Spondyloarthritis
por: Liu, Jing, et al.
Publicado: (2016)

Etanercept prevents TNF-α mediated mandibular bone loss in FcγRIIb(-/-) lupus model
por: Sakunrangsit, Nithidol, et al.
Publicado: (2021)

The TNF-α antagonist etanercept reverses age-related decreases in colonic SERT expression and faecal output in mice
por: Patel, Bhavik Anil, et al.
Publicado: (2017)

DNase I levels in JIA – influence of anti-TNF (etanercept) therapy
por: Vojinovic, J, et al.
Publicado: (2008)

Mapping the certolizumab pegol epitope on TNF and comparison with infliximab, adalimumab and etanercept
por: Henry, Alistair I, et al.
Publicado: (2011)

Reduction of NrF2 as coadjuvant during the development of persistent periapical lesions
por: Guerrero-Bobadilla, Carlos, et al.
Publicado: (2023)

Etanercept Attenuates Traumatic Brain Injury in Rats by Reducing Brain TNF-α Contents and by Stimulating Newly Formed Neurogenesis
por: Cheong, Chong-Un, et al.
Publicado: (2013)

Ankylosing Spondylitis and Rheumatoid Arthritis: Serum Levels of TNF-α and Its Soluble Receptors during the Course of Therapy with Etanercept and Infliximab
por: Schulz, Martin, et al.
Publicado: (2014)

Reduced risk of all-cancer and solid cancer in Taiwanese patients with rheumatoid arthritis treated with etanercept, a TNF-α inhibitor
por: Lan, Joung-Liang, et al.
Publicado: (2017)

Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept
por: Ferreiro-Iglesias, Aida, et al.
Publicado: (2019)

Therapy with soluble TNF receptor (etanercept) induces apoptosis in rheumatoid arthritis (RA) synovium
por: Catrina, AI, et al.
Publicado: (2003)

Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab
por: Neovius, M, et al.
Publicado: (2015)

Etanercept, a Widely Used Inhibitor of Tumor Necrosis Factor-α (TNF- α), Prevents Retinal Ganglion Cell Loss in a Rat Model of Glaucoma
por: Roh, Miin, et al.
Publicado: (2012)

Treatment of male and female spontaneously hypertensive rats with TNF-α inhibitor etanercept increases markers of renal injury independent of an effect on blood pressure
por: Snyder, Elizabeth C., et al.
Publicado: (2022)

Use of anti-TNF Etanercept in paediatric patients with autoimmune disease and ocular involvement: the Parma experience
por: Rossi, M, et al.
Publicado: (2008)

Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept
por: Duret, Pierre-Marie, et al.
Publicado: (2020)

Addition of a Viral Immunomodulatory Domain to Etanercept Generates a Bifunctional Chemokine and TNF Inhibitor
por: Alejo, Alí, et al.
Publicado: (2019)

Etanercept biosimilars
por: Azevedo, Valderilio F., et al.
Publicado: (2014)

Influence of Promoter Polymorphisms of the TNF-α (-308G/A) and IL-6 (-174G/C) Genes on Therapeutic Response to Etanercept in Rheumatoid Arthritis
por: Jančić, Ivan, et al.
Publicado: (2015)

Dendritic Spine and Synaptic Plasticity in Alzheimer’s Disease: A Focus on MicroRNA
por: Reza-Zaldivar, Edwin Estefan, et al.
Publicado: (2020)

Continuous Use of Etanercept During Pregnancy Does Not Affect TNF-Alpha Levels in Umbilical Cord Blood
por: Nishide, Masayuki, et al.
Publicado: (2022)

A Three-Dimensional Alzheimer’s Disease Cell Culture Model Using iPSC-Derived Neurons Carrying A246E Mutation in PSEN1
por: Hernández-Sapiéns, Mercedes A., et al.
Publicado: (2020)

Isoreticular Chemistry and Applications of Supramolecularly Assembled Copper–Adenine Porous Materials
por: Mena-Gutiérrez, Sandra, et al.
Publicado: (2023)

Trypanosoma brucei adenine-phosphoribosyltransferases mediate adenine salvage and aminopurinol susceptibility but not adenine toxicity()
por: Lüscher, Alexandra, et al.
Publicado: (2013)

Concomitant Treatment with Etanercept and Tacrolimus Synergistically Attenuates Arthritis Progression via Inhibition of Matrix Metalloproteinase-3 Production and Osteoclastogenesis in Human TNF-α Transgenic Mice
por: Seki, Iwao, et al.
Publicado: (2019)

Potential Effects of MSC-Derived Exosomes in Neuroplasticity in Alzheimer’s Disease
por: Reza-Zaldivar, Edwin E., et al.
Publicado: (2018)

Effectiveness and safety of a biosimilar-to-biosimilar switch of the TNF inhibitor etanercept in patients with chronic inflammatory rheumatic diseases
por: Kiltz, Uta, et al.
Publicado: (2022)

Treatment of LADA With Etanercept
por: Montes, Vince N., et al.
Publicado: (2012)

Etanercept-associated myelitis
por: Finke, Carsten, et al.
Publicado: (2015)

Etanercept-associated Nephropathy
por: Ammar, Awais, et al.
Publicado: (2019)

Etanercept in axial spondyloarthritis
por: Luo, Gui, et al.
Publicado: (2022)

Observational study of inflammatory arthritis treatment by etanercept originator switched to an etanercept biosimilar
por: Felis-Giemza, Anna, et al.
Publicado: (2019)

Incidence of and Reasons and Determinants Associated with Retransitioning from Biosimilar Etanercept to Originator Etanercept
por: Meijboom, Rosanne W., et al.
Publicado: (2021)

Development of the endocrine pancreas and novel strategies for β-cell mass restoration and diabetes therapy
por: Márquez-Aguirre, A.L., et al.
Publicado: (2015)

Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies
por: Hirabara, Shinya, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ku32gmejmvh8j4iqqions9stpd